Amid the coronavirus pandemic, the US Food and Drug Administration has issued guidance on potency assays for manufacturers of monoclonal antibodies and other therapeutic proteins to treat COVID-19.
Arizona dispensaries are required to test cannabis products for potency and contaminants. Testing regulations, implemented in 2020, cover potency and contamination from microbials, heavy metals and ...